Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM139 antisense RNA 1 (TMEM139-AS1) is a human long non-coding RNA (lncRNA) gene located on chromosome 7. As an antisense RNA, it is not believed to encode a functional protein. Instead, it likely plays a role in regulating the expression of its overlapping or nearby sense gene(s), possibly TMEM139, through RNA-RNA, RNA-DNA, or RNA-protein interactions that modulate transcription, mRNA stability, or epigenetic states[1][3][5][7]. Antisense lncRNAs in general can control gene expression at multiple levels, for example, by interfering with transcription, affecting mRNA stability, or recruiting chromatin modifiers for epigenetic regulation[2][9]. However, there1 is currently no direct evidence or published data specifying a unique functional or disease role for TMEM139-AS1 or associating it with human pathology, nor are there known therapeutic drugs or biomarker applications involving this RNA. As such, it is not considered a defined therapeutic target (i.e., not a receptor, enzyme, transporter, etc.)[5][7]. The reference synonym AC073342.1 is provided in genome resource databases as an alternative name[7]. Summary: - TMEM139-AS1 is a non-coding, antisense long RNA gene with currently unknown specific biological or disease function. - There is no data associating TMEM139-AS1 with drugs, mechanism of action, or use as a biomarker. - It is not a therapeutic target in the conventional sense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMEM139 antisense RNA 1 (TMEM139-AS1).